Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Philipp Sievers

Showing results (11-20 of 124) with videos related to

Pageof 13
Sort By:
Acta Neuropathologica Communications|October 24, 2023
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 statusArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, et al.
Acta Neuropathologica Communications|June 20, 2024
A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneityDavid Gorodezki, Jason Chiang, Angela N Viaene, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Transcriptomic landscape identifies two unrecognized ependymoma subtypes and novel pathways in medulloblastomaSonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2026
Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findingsArnault Tauziède-Espariat, Pierre Khneisser, Dominique Berrebi, et al.
Acta Neuropathologica|June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulationsKonstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Acta Neuropathologica Communications|January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapsesKonstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Neuro-Oncology|October 29, 2025
Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biologySonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Acta Neuropathologica Communications|February 12, 2026
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastomaObada T Alhalabi, Lukas Klein, Kirill Mironov, et al.
Genes & Development|August 25, 2022
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in miceFrank Szulzewsky, Sonali Arora, Aleena K S Arakaki, et al.
Translational Oncology|September 11, 2020
Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02Caroline von Achenbach, Emilie Le Rhun, Felix Sahm, et al.
Pageof 13

Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
Acta Neuropathologica Communications|October 24, 2023
Refinement of diagnostic criteria for pediatric-type diffuse high-grade glioma, IDH- and H3-wildtype, MYCN-subtype including histopathology, TP53, MYCN and ID2 statusArnault Tauziède-Espariat, Emmanuelle Uro-Coste, Yvan Nicaise, et al.
Acta Neuropathologica Communications|June 20, 2024
A multi-institutional series of a novel, recurrent TRIM24::MET fusion-driven infant-type hemispheric glioma reveals significant clinico-pathological heterogeneityDavid Gorodezki, Jason Chiang, Angela N Viaene, et al.
Biorxiv : the Preprint Server for Biology|November 1, 2024
Transcriptomic landscape identifies two unrecognized ependymoma subtypes and novel pathways in medulloblastomaSonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Virchows Archiv : an International Journal of Pathology|March 12, 2026
Extracranial teratoid medulloepithelioma: A pelvic observation with genetic and epigenetic findingsArnault Tauziède-Espariat, Pierre Khneisser, Dominique Berrebi, et al.
Acta Neuropathologica|June 7, 2024
Clinically unfavorable transcriptome subtypes of non-WNT/non-SHH medulloblastomas are associated with a predominance in proliferating and progenitor-like cell subpopulationsKonstantin Okonechnikov, Daniel Schrimpf, Jan Koster, et al.
Acta Neuropathologica Communications|January 12, 2023
Comparison of transcriptome profiles between medulloblastoma primary and recurrent tumors uncovers novel variance effects in relapsesKonstantin Okonechnikov, Aniello Federico, Daniel Schrimpf, et al.
Neuro-Oncology|October 29, 2025
Integrated transcriptomic landscape of medulloblastoma and ependymoma reveals novel tumor subtype-specific biologySonali Arora, Nicholas Nuechterlein, Matt Jensen, et al.
Acta Neuropathologica Communications|February 12, 2026
MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastomaObada T Alhalabi, Lukas Klein, Kirill Mironov, et al.
Genes & Development|August 25, 2022
Both YAP1-MAML2 and constitutively active YAP1 drive the formation of tumors that resemble NF2 mutant meningiomas in miceFrank Szulzewsky, Sonali Arora, Aleena K S Arakaki, et al.
Translational Oncology|September 11, 2020
Sensitivity of human meningioma cells to the cyclin-dependent kinase inhibitor, TG02Caroline von Achenbach, Emilie Le Rhun, Felix Sahm, et al.
Pageof 13